MTM(SH:688029)2020-04-28 16:00Financial Performance - Operating revenue for the period was approximately ¥246.76 million, representing a decline of 14.02% year-on-year[4]. - Net profit attributable to shareholders was approximately ¥47.38 million, down 25.90% from the previous year[4]. - Basic earnings per share were ¥0.3553, a decrease of 44.43% compared to ¥0.6394 in the previous year[5]. - The weighted average return on equity was 1.90%, a decrease of 8.56 percentage points from 10.46% in the previous year[4]. - The net profit attributable to shareholders decreased by 34.41% to 41,497,238.92, influenced by reduced operating income[15]. - Basic and diluted earnings per share fell by 44.43% to 0.3553, reflecting the decrease in net profit[15]. - Total operating revenue for Q1 2020 was RMB 246,764,879.52, a decrease of 13.99% from RMB 286,989,648.38 in Q1 2019[30]. - Net profit for Q1 2020 was RMB 44,690,335.68, a decline of 33.73% compared to RMB 67,449,242.34 in Q1 2019[32]. - Total comprehensive income for Q1 2020 was CNY 53,586,841.85, compared to CNY 54,527,206.46 in Q1 2019, a decrease of 1.7%[35]. Cash Flow and Assets - The net cash flow from operating activities was approximately -¥21.41 million, a significant decrease of 145.99% compared to the same period last year[4]. - Cash flow from operating activities was CNY 277,892,990.30 in Q1 2020, down from CNY 309,010,063.90 in Q1 2019, a decrease of 10.0%[36]. - The total cash and cash equivalents at the end of the period reached 701,074,206.06 RMB, an increase from 646,767,770.49 RMB at the beginning of the period[38]. - Total assets at the end of the reporting period were approximately ¥2.86 billion, a decrease of 0.70% compared to the end of the previous year[4]. - Total current assets amounted to approximately CNY 2.37 billion, a slight decrease from CNY 2.40 billion at the end of 2019[24]. - The company reported cash and cash equivalents of approximately ¥491.85 million and total current assets of ¥2,222.96 billion as of January 1, 2020[45]. Liabilities and Equity - The total liabilities decreased to CNY 287.46 million from CNY 347.16 million compared to the previous year[25]. - Shareholders' equity reached approximately ¥2,528.10 billion, with total equity attributable to shareholders at ¥2,475.01 billion[43]. - The total liabilities were reported at ¥347.16 billion, with current liabilities totaling ¥317.08 billion and non-current liabilities at ¥30.09 billion[43]. - The company’s total current liabilities included accounts payable of approximately $119.02 million[46]. Research and Development - Research and development expenses accounted for 7.29% of operating revenue, an increase of 2.61 percentage points year-on-year[5]. - Research and development expenses rose by 33.96% to 18,001,211.42, driven by increased costs for trial materials and patent applications[13]. - Research and development expenses increased to RMB 18,001,211.42 in Q1 2020, up 33.57% from RMB 13,438,079.54 in Q1 2019[30]. Shareholder Information - The total number of shareholders at the end of the reporting period was 9,098[7]. - The top shareholder, Nanjing Xinweichuang Enterprise Management Consulting Co., Ltd., held 30,762,400 shares, accounting for 23.07% of total shares[7]. Government Subsidies and Other Income - Government subsidies recognized in the current period amounted to approximately ¥3.70 million, contributing positively to the financial results[6]. - The company reported a significant increase in government subsidies, with operating income from other sources rising by 523.50% to 5,269,292.21[13]. - Investment income increased by 69.37% to 3,577,617.78, attributed to returns from financial products[13]. - The company reported an investment income of CNY 9,962,755.68 in Q1 2020, significantly higher than CNY 2,112,286.88 in Q1 2019, an increase of 371.5%[34]. Inventory and Receivables - Inventory increased to CNY 238.35 million from CNY 211.60 million year-over-year[24]. - Accounts receivable decreased to CNY 148.27 million from CNY 170.15 million compared to the previous year[23]. - Other receivables increased to RMB 13,036,838.09 in Q1 2020, compared to RMB 5,524,718.70 in Q1 2019[28]. Changes in Financial Standards - The company executed a new revenue recognition standard effective January 1, 2020, reclassifying prepayments and deferred income into contract liabilities[44]. - The company implemented new revenue recognition standards starting January 1, 2020, reclassifying advance payments to contract liabilities[47].